Estrella Immunopharma Balance Sheet Health
Financial Health criteria checks 3/6
Estrella Immunopharma has a total shareholder equity of $746.3K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.7M and $3.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.80m |
| Equity | US$746.29k |
| Total liabilities | US$2.99m |
| Total assets | US$3.74m |
Financial Position Analysis
Short Term Liabilities: ESLA's short term assets ($2.2M) do not cover its short term liabilities ($3.0M).
Long Term Liabilities: ESLA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ESLA is debt free.
Reducing Debt: ESLA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ESLA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ESLA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 90.8% each year